With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising ...
Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years ...
Berobenatide injections would only need to be taken 12 times a year rather than 52 with weekly injections.